Drug portfolio management teams devote more time, money to niche brands, study finds
RESEARCH TRIANGLE PARK, N.C. — Drug companies’ pharmaceutical portfolio management teams spend most of their time and budgets supporting niche products, according to a new study.
The study, "Pharmaceutical Portfolio Management: Selecting Targets, Filling Pipelines and Preparing for Post-Launch Success," by Cutting Edge Information, found that portfolio management teams spend 53% of their time supporting niche products, meaning those with less than $500 million in annual sales. They also spend an average of 59% of their budgets on niche drug compounds, compared with 18% on potential blockbusters.
"The focus on niche drugs makes sense, as drugs with the potential to become blockbusters lose that opportunity as they progress through the development cycle," Cutting Edge Information CEO Jason Richardson said. "As more blockbusters go generic, niche compounds treating conditions with lower rates of incidence become more attractive targets for pharmaceutical companies."
FDA approves Lupin generic contraceptive
MUMBAI, India — The Food and Drug Administration has approved a contraceptive therapy made by Lupin Pharmaceuticals, the Indian drug maker said Friday.
Lupin announced the approval of Daysee (levonorgestrel and ethinyl estradiol tablets and ethinyl estradiol tablets) in the 0.15-mg/0.03-mg and 0.01-mg strengths.
The drug is a generic version of Teva’s Seasonique. Various versions of the drug had sales of $161 million in 2012, according to IMS Health.
RxWiki launches beta version of mobile pharmacy app
AUSTIN, Texas — The makers of a new smartphone app say it will synchronize engagement between pharmacists and patients through mobile devices, social media, websites and printed media.
RxWiki announced Friday the beta release of Mobile+, a customizable mobile application that delivers medication information, news and alerts to patients’ smartphones. The app is currently available for Android devices and will soon be available for Apple devices.
"With millions of patients searching for health information on their smartphones, there is a major opportunity for pharmacists to connect with patients outside the pharmacy," RxWiki publisher and CEO Donald Hackett said. "RxWiki Mobile+ enables pharmacists to prescribe trusted information to patients on any digital device, at any time, wherever they are."
Features include integration of the pharmacy’s branding within the app, a touch-to-call option to dial the pharmacy’s telephone number and news feeds customizable by health condition.
According to Pew Internet research, 1-out-of-every-3 minutes spent online is on a smartphone, and research2guidance estimates that within two years, about 500 million people worldwide will be using healthcare mobile apps.
"The rapid adoption of mobile devices gives community pharmacists another opportunity to improve medication therapy management and reduce costs," Hackett said. "RxWiki’s Digital Pharmacist network members can ensure their patients receive trusted, consistent information throughout the medication delivery experience provided by RxWiki Mobile+."